Neoplasms, Colorectal Completed Phase 1 / 2 Trials for Labetuzumab (DB05097)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041652Safety Study of hMN14 to Treat Either Colorectal or Breast CancerTreatment
NCT00040599Safety Study of 90Y-hMN14 to Treat Colorectal CancerTreatment